Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
This study sought to determine the effects of microneedle coating formulation, drying time and storage time on antigen stability and in vivo immunogenicity of influenza microneedle vaccines.
The stability of inactivated influenza virus vaccine was monitored by hemagglutination (HA) activity and virus particle aggregation as a function of storage time and temperature with or without trehalose. In vivo immunogenicity of inactivated influenza vaccines coated onto microneedles was determined in mice by virus-specific antibody titers and survival rates.
In the absence of trehalose, HA activity decreased below 10% and to almost zero after 1 h and 1 month of drying, respectively. Addition of trehalose maintained HA activity above 60% after drying and above 20% after 1 month storage at 25°C. Loss of HA activity generally correlated with increased virus particle aggregation. Administration of microneedles coated with trehalose-stabilized influenza vaccine yielded high serum IgG antibody titers even after 1 month storage, and all animals survived with minimal weight loss after lethal challenge infection.
Inactivated influenza virus vaccine coated on microneedles with trehalose significantly improved the HA activity as well as in vivo immunogenicity of the vaccine after an extended time of storage.
- Palese P. Influenza: old and new threats. Nat Med. 2004;10:S82–7. CrossRef
- Monto AS, Ohmit SE. Seasonal influenza vaccines: evolutions and future trends. Expert Rev Vaccines. 2009;8:383–9. CrossRef
- Cox NJ, Subbarao K. Influenza. Lancet. 1999;354:1277–82. CrossRef
- Doherty PC, Turner SJ, Webby RG, Thomas PG. Influenza and the challenge for immunology. Nat Immunol. 2006;7:449–55. CrossRef
- Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194:S111–8. CrossRef
- Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. Philadelphia: Saunders Elsevier; 2008. p. 259–90.
- Raviv Y, Blumenthal R, Tompkins SM, Humberd J, Hogan RJ, Viard M. Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity. J Virol. 2008;82:4612–9. CrossRef
- Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int. 2004;19:95–103. CrossRef
- Hamilton JG. Needle phobia—a neglected diagnosis. J Fam Pract. 1995;41:169–75.
- Drucker E, Alcabes PG, Marx PA. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet. 2001;358:1989–92. CrossRef
- Weniger BG, Papania MJ. Alternative vaccine delivery methods. In: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. Philadelphia: Saunders Elsevier; 2008. p. 1357–92.
- Mitragotri S. Immunization without needles. Nat Rev Immunol. 2005;5:905–16. CrossRef
- Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J et al. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. J Infect Dis. 2008;198:650–8. CrossRef
- Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351:2295–301. CrossRef
- Belshe RB. Current status of live attenuated influenza virus vaccine in the US. Virus Res. 2004;103:177–85. CrossRef
- Chen ZY, Santos C, Aspelund A, Gillim-Ross L, Jin H, Kemble G et al. Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets. J Virol. 2009;83:65–72. CrossRef
- Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Enhanced memory responses to H1N1 influenza vaccination in the skin using vaccine coated-microneedles. J Infect Dis. 2010;201:190–8. CrossRef
- Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK. Microneedle-based vaccines. Curr Top Microbiol Immunol. 2009;333:369–93. CrossRef
- Widera G, Johnson J, Kim L, Libiran L, Nyam K, Daddona PE et al. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine. 2006;24:1653–64. CrossRef
- Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release. 2007;117:227–37. CrossRef
- Koutsonanos DG, Martin MDP, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR et al. Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS ONE. 2009;4:e4773. CrossRef
- Zhu QY, Zarnitsyn VG, Ye L, Wen ZY, Gao YL, Pan L et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci USA. 2009;106:7968–73. CrossRef
- Andrianov AK, DeCollibus DP, Gillis HA, Kha HH, Marin A, Prausnitz MR et al. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci USA. 2009;106:18936–41. CrossRef
- Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585–94. CrossRef
- Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release. 2010;142:187–95. CrossRef
- Hinrichs WLJ, Prinsen MG, Frijlink HW. Inulin glasses for the stabilization of therapeutic proteins. Int J Pharm. 2001;215:163–74. CrossRef
- Sun WQ, Leopold AC, Crowe LM, Crowe JH. Stability of dry liposomes in sugar glasses. Biophys J. 1996;70:1769–76. CrossRef
- Bieganski RM, Fowler A, Morgan JR, Toner M. Stabilization of active recombinant retroviruses in an amorphous dry state with trehalose. Biotechnol Prog. 1998;14:615–20. CrossRef
- Amorij JP, Meulenaar J, Hinrichs WLJ, Stegmann T, Huckriede A, Coenen F et al. Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying. Vaccine. 2007;25:6447–57. CrossRef
- Molina MD, Armstrong TK, Zhang Y, Patel MM, Lentz YK, Anchordoquy TJ. The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci. 2004;93:2259–73. CrossRef
- Amorij JP, Huckriede A, Wischut J, Frifflink HW, Hinrichs WLJ. Development of stable influenza vaccine powder formulations: challenges and possibilities. Pharm Res. 2008;25:1256–73. CrossRef
- Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Improved influenza vaccination in the skin using vaccine coated-microneedles. Vaccine. 2009;27:6932–8. CrossRef
- Quan FS, Kim YC, Yoo DG, Compans RW, Prausnitz MR, Kang SM. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin. PLoS ONE. 2009;4:e7152. CrossRef
- Berhane Y, Demissie M. Cold chain status at immunisation centres in Ethiopia. East Afr Med J. 2000;77:476–9.
- Bloom BR. Vaccines for the third-world. Nature. 1989;342:115–20. CrossRef
- Ameri M, Daddona PE, Maa YF. Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system. Pharm Res. 2009;26:2454–63. CrossRef
- Quan FS, Compans RW, Nguyen HH, Kang SM. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J Virol. 2008;82:1350–9. CrossRef
- Hierholz JC, Suggs MT. Standardized viral hemagglutination and hemagglutination-inhibition test. I. Standardization of erythrocyte suspensions. Appl Microbiol. 1969;18:816–23.
- Skountzou I, Quan FS, Jacob J, Compans RW, Kang SM. Transcutaneous immunization with inactivated influenza virus induces protective immune responses. Vaccine. 2006;24:6110–9. CrossRef
- Spellberg B, Edwards JE. Type 1 type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76–102. CrossRef
- Steinhauer DA. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology. 1999;258:1–20. CrossRef
- Coenen F, Tolboom JTBM, Frijlink HW. Stability of influenza sub-unit vaccine—does a couple of days outside the refrigerator matter? Vaccine. 2006;24:525–31. CrossRef
- Lambert PH, Laurent PE. Intradermal vaccine delivery: will new delivery systems transform vaccine administration? Vaccine. 2008;26:3197–208. CrossRef
- Stability Kinetics of Influenza Vaccine Coated onto Microneedles During Drying and Storage
Volume 28, Issue 1 , pp 135-144
- Cover Date
- Print ISSN
- Online ISSN
- Springer US
- Additional Links
- inactivated virus vaccine
- influenza virus
- long-term stability
- Industry Sectors
- Author Affiliations
- 1. School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, 30332, USA
- 2. Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, 30322, USA